Article
Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma.
Journal of Clinical Oncology
(2017)
Disciplines
Publication Date
January 31, 2017
Citation Information
Michael B. Atkins, Ragini Reiney Kudchadkar, Mario Sznol, David F. McDermott, et al.. "Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma." Journal of Clinical Oncology (2017) Available at: http://works.bepress.com/walter-urba/100/